07 September 2010

You simply can't do both

Breast Cancer Action, a San Francisco-based advocacy group that seeks to educate the public about potential causes of breast cancer, has a new campaign for Fall 2010. BCA seeks 6,220 signatures for a petition they will send to Eli Lilly, a corporation which makes both rBGH (a potential cancer causing hormone primarily used in dairy cows) AND breast cancer drugs. So far BCA has reached about half the signatures they need. The reason for 6,220 signatures is to equal one signature for each day that rBGH has been on the market.

Please sign the petition, and spread the word.

No comments: